
ATS 2026 findings highlighted bleeding risks and hemodynamic responses with sotatercept in CTD-associated pulmonary arterial hypertension (PAH).
Rogerio Souza, MD, PhD, is a professor of pulmonary medicine and head of the Pulmonary Circulation Program at the University of Sao Paulo Medical School.

ATS 2026 findings highlighted bleeding risks and hemodynamic responses with sotatercept in CTD-associated pulmonary arterial hypertension (PAH).
